Ledger.Open graph →
SEC Form D · Amendment · filed May 26, 2021

Stingray Therapeutics, Inc

Offering
$3.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Scott A. Jordan · Houston, TXExec · Director · PromoterJonathan P. Northrup · Houston, TXExec · Director · PromoterSunil P. Sharma · Houston, TXExec · Director · PromoterGarth Ebanks · Grand Cayman, Cayman IslandsExec · Director · PromoterJoseph T. Phoenix · Boston, MAExec · Director · PromoterJohn J. Schreiber · Boston, MAExec · Director · PromoterWilliam S. Seybold · San Fransisco, CAExec · Director · PromoterPhilip D. Dreyfuss · San Fransisco, CAExec · Director · Promoter325 Capital LLC · NEW YORK, NYExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗